Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Menke

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2002
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutationC M E Contant, M B E Menke-Pluijmers, C Seynaeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisB A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, et al.
Investigative Radiology|July 3, 2015
Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast CancerAlexander M Th Schmitz, Wouter B Veldhuis, Marian B E Menke-Pluijmers, et al.
Breast Cancer Research and Treatment|October 24, 2007
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patientsMieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.
Breast Cancer Research and Treatment|July 20, 2012
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrencesAnnemiek B G Kwast, Karin C G M Groothuis-Oudshoorn, Ilse Grandjean, et al.
Annals of Surgical Oncology|June 2, 2007
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer ClinicBernadette A M Heemskerk-Gerritsen, Cecile T M Brekelmans, Marian B E Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Hereditary Cancer in Clinical Practice|April 3, 2009
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyMurly B M Tan, Eveline M A Bleiker, Marian B E Menke-Pluymers, et al.
Plos One|September 27, 2017
Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRIA M T Schmitz, W B Veldhuis, M B E Menke-Pluijmers, et al.
The New England Journal of Medicine|August 14, 2009
Micrometastases or isolated tumor cells and the outcome of breast cancerMaaike de Boer, Carolien H M van Deurzen, Jos A A M van Dijck, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2002
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutationC M E Contant, M B E Menke-Pluijmers, C Seynaeve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysisB A M Heemskerk-Gerritsen, M B E Menke-Pluijmers, A Jager, et al.
Investigative Radiology|July 3, 2015
Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast CancerAlexander M Th Schmitz, Wouter B Veldhuis, Marian B E Menke-Pluijmers, et al.
Breast Cancer Research and Treatment|October 24, 2007
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patientsMieke Kriege, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.
Breast Cancer Research and Treatment|July 20, 2012
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrencesAnnemiek B G Kwast, Karin C G M Groothuis-Oudshoorn, Ilse Grandjean, et al.
Annals of Surgical Oncology|June 2, 2007
Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer ClinicBernadette A M Heemskerk-Gerritsen, Cecile T M Brekelmans, Marian B E Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer casesC T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Hereditary Cancer in Clinical Practice|April 3, 2009
Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomyMurly B M Tan, Eveline M A Bleiker, Marian B E Menke-Pluymers, et al.
Plos One|September 27, 2017
Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRIA M T Schmitz, W B Veldhuis, M B E Menke-Pluijmers, et al.
The New England Journal of Medicine|August 14, 2009
Micrometastases or isolated tumor cells and the outcome of breast cancerMaaike de Boer, Carolien H M van Deurzen, Jos A A M van Dijck, et al.
Pageof 10